Nanomedicine-Nanotechnology Biology and Medicine
Scope & Guideline
Elevating Medical Research with Nanotechnology Insights
Introduction
Aims and Scopes
- Nanoparticle Development for Drug Delivery:
Research on the design and synthesis of nanoparticles for targeted drug delivery systems, enhancing the bioavailability and therapeutic efficacy of various drugs. - Nanotechnology in Cancer Treatment:
Exploration of nanomedicines and their applications in cancer therapy, focusing on mechanisms of action, efficacy, and safety in clinical settings. - Biocompatibility and Safety Assessments:
Evaluation of the biocompatibility and safety of nanomaterials used in biomedical applications, including toxicity studies and regulatory considerations. - Innovative Diagnostic Techniques:
Development of nanoparticle-based diagnostic tools and imaging techniques aimed at early disease detection and monitoring, including the use of biosensors and imaging agents. - Theranostic Applications:
Integration of therapeutic and diagnostic capabilities in nanomedicine, allowing for simultaneous treatment and monitoring of disease progression. - Nanomaterials for Regenerative Medicine:
Use of nanotechnology in tissue engineering and regenerative medicine, focusing on scaffolds, drug delivery systems, and cellular interactions.
Trending and Emerging
- Nanoparticle-Enabled Immunotherapy:
An increasing number of studies focus on the use of nanoparticles to enhance immunotherapy, indicating a growing interest in integrating nanotechnology with immune modulation for cancer treatment. - CRISPR and Gene Editing Technologies:
Research involving nanoparticles for gene editing applications, particularly CRISPR/Cas9 delivery systems, is on the rise, showcasing the potential of nanotechnology in genetic therapies. - Microfluidics for Nanoparticle Synthesis:
The application of microfluidic technologies for the synthesis and characterization of nanoparticles is emerging as a significant trend, providing precise control over particle properties and functions. - Extracellular Vesicles as Nanocarriers:
A growing body of work is exploring the use of extracellular vesicles derived from cells as natural nanocarriers for drug delivery, highlighting advancements in biocompatible and targeted therapies. - Personalized Nanomedicine:
There is an increasing trend towards personalized approaches in nanomedicine, with research focusing on tailoring nanoparticle formulations based on individual patient profiles and disease characteristics. - Nanotechnology for Chronic Disease Management:
Emerging studies are increasingly targeting chronic diseases, such as diabetes and cardiovascular conditions, using nanotechnology for improved therapeutic outcomes and monitoring.
Declining or Waning
- Traditional Small Molecule Drug Delivery Systems:
Research focusing on conventional small molecule drug delivery methods is becoming less prevalent, as the field shifts towards more innovative, nanoparticle-based approaches. - Invasive Surgical Techniques:
The exploration of invasive techniques in conjunction with nanotechnology is waning, with a greater emphasis on non-invasive or minimally invasive approaches using nanomaterials. - Single-Modal Therapies:
There is a noticeable decline in studies dedicated solely to single-modal therapies, as the field moves towards combination therapies that integrate nanotechnology with immunotherapy or other modalities. - Basic Physicochemical Characterization:
While foundational studies are important, there is a diminishing focus on basic physicochemical characterization of nanoparticles without direct applications, as researchers prioritize functional and therapeutic outcomes.
Similar Journals
Nanomedicine
Exploring the Intersection of Nanotechnology and MedicineNanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.
Cancer Nanotechnology
Unlocking the Potential of Nanotechnology in OncologyCancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.
Biomedical Materials
Shaping Tomorrow's Healthcare with Cutting-Edge Materials.Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Unlocking New Horizons in Pharmaceutical ResearchBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
BME Frontiers
Pioneering Insights for Tomorrow's Medical TechnologiesBME Frontiers, published by the American Association for the Advancement of Science, is an innovative open-access journal dedicated to the burgeoning field of Biomedical Engineering. Since its establishment in 2020, this journal has aimed to bridge the gap between cutting-edge research and practical application, promoting advancements in biomedical technologies, medical devices, and healthcare solutions. Boasting impressive rankings within Scopus—64th among 398 in Medicine (miscellaneous) and 81st among 303 in Biomedical Engineering—BME Frontiers stands out as a significant contributor to scholarly communication, offering rich insights for researchers, professionals, and students alike. With consistent publication projected through 2024, the journal serves as an essential platform for disseminating high-quality research that can drive innovation and inspire new approaches in the healthcare sector.
Regenerative Biomaterials
Elevating Standards in Regenerative BiomaterialsRegenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.
ACS Biomaterials Science & Engineering
Connecting Research and Application for a Healthier TomorrowACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.
Nanotechnology Science and Applications
Exploring Innovations in Bioengineering and Beyond.Nanotechnology Science and Applications, published by DOVE MEDICAL PRESS LTD, is a premier open-access journal dedicated to advancing knowledge in the fields of nanoscience and nanotechnology, particularly focusing on their applications in bioengineering, biomedical engineering, and pharmaceutical sciences. Since its inception in 2008, this journal has provided a platform for the dissemination of high-quality research that is rigorously peer-reviewed, ensuring that only the most impactful findings reach a global audience. With an impressive impact factor reflected in its recent categorization in the Q1 tier for Pharmaceutical Science and Q2 for Bioengineering and Nanoscience, it stands as a critical resource for researchers, practitioners, and students eager to explore the cutting-edge innovations within these rapidly evolving disciplines. The journal's commitment to accessibility and its robust indexing in Scopus—ranked highly in its respective categories—reinforces its importance as a leading forum for the exchange of scientific knowledge and the fostering of collaborative research in nanotechnology applications.
Biomaterials Research
Unveiling the potential of biomaterials for healthcare.Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.
BioImpacts
Elevating global discourse in medical and pharmaceutical advancements.BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.